Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2005
08/31/2005CN1216907C Adverse-resistance transcription factor from tomato, its coding gene and application
08/31/2005CN1216906C Transcription factor capable of regulating and controlling soybean adverse resistance, its coding gene and application
08/31/2005CN1216905C Transcription factor for regulating and controlling dry land cotton anti contrary property and its coded gene and application
08/31/2005CN1216904C Soybean ethylene response protein transcription factor and its coded gene and application
08/31/2005CN1216903C Ethylene response conjugated protein transcription factor of ice plant and tis coded gene and application
08/31/2005CN1216901C Method for cleaving chimeric protein using processing enzyme
08/31/2005CN1216900C Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
08/31/2005CN1216641C Monoclonal human matural antibodies
08/31/2005CN1216640C Live vaccine for human immunodeficiency virus
08/31/2005CN1216638C Genes coding proteins for early liver development and their use indiagnosing and treating liver disease
08/30/2005US6936755 stalk and root lodging resistance; good early growth, stay green and test weight; very good dry down, ear retention and husk cover, and dependable drought stress tolerance; good disease resistance
08/30/2005US6936750 Isolated nucleic acid molecules encoding Na+/H+ exchanger polypeptides for extrusion of monovalent cations, most preferably sodium ions from the cytosol of cells to provide the cell with increased salt tolerance
08/30/2005US6936749 Nonsymbiotic plant hemoglobins to maintain cell energy status
08/30/2005US6936748 Polyphenol oxidase genes from potato tuber, grape, apple and broad bean
08/30/2005US6936747 Methods for the replacement, translocation and stacking of DNA in eukaryotic genomes
08/30/2005US6936728 Production of hydroxylated fatty acids in genetically modified plants
08/30/2005US6936708 Expression of Alfin 1 and methods for producing transgenic plants having increased root growth and root specific gene activation
08/30/2005US6936707 Modified DNA molecule, recombinant containing the same, and uses thereof
08/30/2005US6936705 nucleic acid sequence that is an insert of a clone selected from the group consisting of: yeast artificial chromosome, isolable from a transformant identified by international deposit number FERM BP-4271; BP-4273; BP-4274
08/30/2005US6936704 a nucleotide sequence which hybridizes to the complement of the specific nucleic acid molecule over its full length under conditions of incubation and encodes a polypeptide which costimulates T cell proliferation in vitro
08/30/2005US6936702 Charge-switch nucleotides
08/30/2005US6936698 Genetically engineered immunoglobulin; for use in treatment of hematopoietic defects
08/30/2005US6936696 Modified proteins having an increased number of essential amino acids; transformed host cells, transgenic plants and seeds containing the enhanced proteins, and methods for preparing and using them
08/30/2005US6936695 Manufacture and expression of large structural genes
08/30/2005US6936694 [Met--1, des-Cys1, des-Tyr2, des-Cys3]IFN- gamma polypeptide produced by a DNA sequence coding in a transformant organism, and such polypeptide having the characteristics of human immune interferon
08/30/2005US6936693 Specific polypeptides, useful as nematocides
08/30/2005US6936692 Binding antibodies; culture product; gene therapy; chromosome mapping
08/30/2005US6936691 Secreted protein HCE3C63
08/30/2005US6936689 Peptide antagonists of zonulin and methods for use of the same
08/30/2005US6936688 Nucleotide sequences coding polypeptide for use in the treatment of leukemia, tumors, infections, autoimmune disease, and fibrotic disorders; wound healing agent
08/30/2005US6936687 Compositions for the detection of enzyme activity in biological samples and methods of use thereof
08/30/2005US6936617 Nitrogen compounds such as 6-chloro-3-ethyl-2-(2-thiazol-2-yl -imidazol-1-ylmethyl)-imidazo(1,2-b)pyridazine used for prophylaxis of nervous system disorders
08/30/2005US6936595 Tumour-specific vector for gene therapy
08/30/2005US6936593 Method of down-regulating gene expression
08/30/2005US6936585 Corticotropin releasing factor 2 receptor agonists
08/30/2005US6936475 Hybrid green fluorescent protein (GFP) which binds, measures and detects calcium using fluorescent/chemiluminescence resonance energy transfer (F/CRET)
08/30/2005US6936470 Rapid and enzymeless cloning of nucleic acid fragments
08/30/2005US6936469 Methods for delivering nucleic acid molecules into cells and assessment thereof
08/30/2005US6936467 Nucleotide sequences for use in the repair of genetic damage
08/30/2005US6936466 Nucleotide sequences coding polypeptide for use in the treatment of hereditary respiratory system disorders
08/30/2005US6936465 Plasmid vector comprising a retroviral integrase gene and an integrase recognition region
08/30/2005US6936461 Method for immobilizing multistranded nucleic acid molecules by modifying more than one strand thereof, and binding each strand to a solid support
08/30/2005US6936458 Isolated DNA comprising one or more genes specific for 5S clavam biosynthesis, vectors comprising such DNA and streptomyces hosts capable of improved clavulanic acid production
08/30/2005US6936457 DNA ENCODING HUMAN α AND β SUBUNITS OF NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR, CELLS TRANSFORMED THEREWITH, AND RECOMBINANT CELL LINE EXPRESSING A HUMAN α AND β SUBUNIT OF NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR
08/30/2005US6936455 heterologous polypeptide is initially expressed in the form of cytoplasmic inclusion bodies in the host cell, the inclusion bodies are isolated and subsequently treated so that the desired heterologous polypeptide is cleaved autoproteolytically
08/30/2005US6936453 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
08/30/2005US6936452 Inhibitors of the inositol polyphosphate 5-phosphate SHIP2 molecule
08/30/2005US6936449 Regulatable growth of filamentous fungi
08/30/2005US6936445 Comprises hydrolase for N-benzylazetidine-2-carboxylic acid ester immolbilized on poroous divinylbenzene-styrene copolymer
08/30/2005US6936442 Amplification; genetic engineering
08/30/2005US6936440 Selecting ligand agonists and antagonists
08/30/2005US6936438 Method of producing a polypeptide using oxaloacetate hydrolase deficient fungal host cells
08/30/2005US6936425 Attenuated salmonella SP12 mutants as antigen carriers
08/30/2005US6936424 Materials and methods for detection and treatment of breast cancer
08/30/2005US6936422 Staphylococcus culture; genetic engineering
08/30/2005US6936421 Structurally biased random peptide libraries based on different scaffolds
08/30/2005US6936419 used for the detection of cytosine methylations in genomic DNA
08/30/2005US6936418 Methods and compositions for effecting homologous recombination
08/30/2005US6936414 Nucleic acid isolation method and kit
08/30/2005US6936262 Animal feeds; pneumonia vaccine
08/30/2005US6936259 For therapy and prophylaxis of bacterial infections
08/30/2005US6936257 Recombinant Venezuelan equine encephalitis virus vaccine
08/30/2005US6936256 For controlling Infectious Pancreatic Necrosis Virus (IPNV) in aquatic species
08/30/2005US6936254 Method of inducing fetal hemoglobin synthesis
08/30/2005US6936251 Detection using antibodies
08/30/2005US6936248 Methods of inhibiting GPR-9-6 function
08/30/2005US6936243 Adeno-associated viral vector-mediated delivery of DNA to cells of the liver
08/30/2005CA2361912C Methods for modulating water-use efficiency or productivity in a plant
08/30/2005CA2330207C Microneedle devices and methods of manufacture and use thereof
08/30/2005CA2294647C Diagnostic assays using soluble endothelial cell protein c/activated protein c receptor
08/30/2005CA2294566C Ikk-.alpha. proteins, nucleic acids and methods
08/30/2005CA2111983C Plant-derived glutathione-s-transferase, encoding dna and uses thereof
08/30/2005CA2103887C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
08/30/2005CA2001935C Sulfonamide resistance genes and their use
08/30/2005CA1341490C Dna functional group and plasmid coding for hirudine, transformed yeast, preparation process for hirudine, resulting hirudine, and its pharmaceutical use
08/30/2005CA1341489C Family of primate hematopoietic growth factors
08/27/2005CA2555803A1 Pneumolysin derivatives
08/26/2005CA2456595A1 Process for identifying eukariotic tumor cells or bacteria arboring a genomic alteration in at least one part of a gene encoding for a transcription factor
08/25/2005WO2005078449A1 Method and kit for identifying the function of gene product and identifying binding substance
08/25/2005WO2005078445A1 Non-invasive real-time in vivo bioluminescence imaging of local ca2+ dynamics in living organisms
08/25/2005WO2005078122A2 Method for enrichment involving elimination by mismatch hybridisation
08/25/2005WO2005078119A1 Probe for detecting nuclear receptor agonist or antagonist and method of screening agonist or antagonist to nuclear receptor with the use of the same
08/25/2005WO2005078116A1 A method of isolating antibacterial peptides and the isolated peptides thereof
08/25/2005WO2005078113A1 Method for producing l-threonine using bacteria belonging to the genus escherichia
08/25/2005WO2005078112A1 Method of preparing menadione with a recombinant micro-organism
08/25/2005WO2005078111A1 Enzymatic asymmetric decarboxylation of disubstituted malonic acids
08/25/2005WO2005078109A2 Expression of plasminogen and microplasminogen in duckweed
08/25/2005WO2005078108A2 Stress resistant plants
08/25/2005WO2005078107A1 Control of programmed death (pcd) in plants
08/25/2005WO2005078106A1 Orotate transporter encoding marker genes
08/25/2005WO2005078105A2 Selection markers useful for heterologous protein expression
08/25/2005WO2005078104A1 Method for generating tethered proteins
08/25/2005WO2005078103A1 Method for preparing high-purity agarose by using recombinant arylsulfatase
08/25/2005WO2005078102A1 Oligonucleotide for genotyping of mycoplasma, microarray comprising the oligonucleotide, and method for detection of species using the microarray
08/25/2005WO2005078101A2 Use of genes encoding outward potassium channels for modifying at least one phenotype linked to the size and organic acid content of at least one plant storage organ
08/25/2005WO2005078100A1 Method of detecting cancer cell acquiring drug-resistance
08/25/2005WO2005078098A1 Modified cells that co-express blimp1 and a reporter molecule and methods of using the same
08/25/2005WO2005078097A2 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING MULTIFUNCTIONAL SHORT INTERFERING NUCLEIC ACID (Multifunctional siNA)
08/25/2005WO2005078096A2 Dual functional oligonucleotides for use in repressing mutant gene expression
08/25/2005WO2005078095A1 SNP DISCRIMINATORY siRNA